Laboratory of Functional Diagnostics
Head: Otomar Kittnar, MD., Prof., CSc.
Researchers: Jaroslav Slavíček
PhD Students: Eva Medová, Elena Fialová
Key research topics
Body Surface Potential Mapping:
- In people suffering from coronary artery disease
- In patients with non-cardiologic diseases
- In study evaluating an effect of resynchronization therapy in patients with failing heart.
Technologies (methods)
Electrophysiology: Body surface potential mapping (Cardiag, Biosemi).
Publications
ECG body surface mapping in patients with gestational diabetes mellitus and optimal metabolic compensation. Žákovičová E, Kittnar O, Slavíček J, Medová E, Šváb P, Charvát J., Physiol Res. 2014;63 Suppl 4:S479-87.
Gender differences in electrophysiological characteristics of idiopathic ventricular tachycardia originating from right ventricular outflow tract. Yang SG, Mlček M, Kittnar O., Physiol Res. 2014;63 Suppl 4:S451-8.
Estrogen can modulate menopausal women's heart rate variability. Yang SG, Mlček M, Kittnar O., Physiol Res. 2013 Dec 12;62 Suppl 1:S165-71.
QT dispersion and electrocardiographic changes in women with gestational diabetes mellitus. Medová E, Fialová E, Mlček M, Slavíček J, Dohnalová A, Charvát J, Žákovičová E, Kittnar O., Physiol Res. 2012;61 Suppl 2:S49-55.
ECG body surface mapping changes in type 1 diabetic patients with and without autonomic neuropathy. Palová S, Szabo K, Charvát J, Slavícek J, Medová E, Mlcek M, Kittnar O., Physiol Res. 2010;59(2):203-9.
Grants
Kittnar O.: Pathophysiology and early markers of incipient destabilization of cardiorespiratory functions. SVV 260 021, Charles University. Kittnar O.: Pathophysiology and early markers of incipient destabilization of cardiorespiratory functions. SVV 260 021, Charles University.
Riedelbauchova L.: Characteristics of electromechanical dyssynchrony predicting an effect of resynchronisation therapy. MZ-VES 2015, No. 15-31398A
Cooperating institutions
Riedelbauchova L.: Characteristics of electromechanical dyssynchrony predicting an effect of resynchronisation therapy. MZ-VES 2015, No. 15-31398A
Grants: SVV 260 021, MZ-VES 2015, No. 15-31398A